Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

Song J, Sokoll LJ, Pasay JJ, Rubin AL, Li H, Bach DM, Chan DW, Zhang Z.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):174-182. doi: 10.1158/1055-9965.EPI-18-0483. Epub 2018 Oct 17.

PMID:
30333219
2.

Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.

Chan A, Prassas I, Dimitromanolakis A, Brand RE, Serra S, Diamandis EP, Blasutig IM.

Clin Cancer Res. 2014 Nov 15;20(22):5787-95. doi: 10.1158/1078-0432.CCR-14-0289. Epub 2014 Sep 19.

3.

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SM.

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw266.

4.

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.

Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP.

BMC Cancer. 2013 Sep 3;13:404. doi: 10.1186/1471-2407-13-404.

5.

Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.

Dong D, Jia L, Zhang L, Ma N, Zhang A, Zhou Y, Ren L.

Cancer Sci. 2018 Sep;109(9):2841-2851. doi: 10.1111/cas.13712. Epub 2018 Jul 24.

6.

A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma.

Song J, Merbs SL, Sokoll LJ, Chan DW, Zhang Z.

Clin Proteomics. 2019 Mar 5;16:10. doi: 10.1186/s12014-019-9230-8. eCollection 2019.

7.

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.

Shaw VE, Lane B, Jenkinson C, Cox T, Greenhalf W, Halloran CM, Tang J, Sutton R, Neoptolemos JP, Costello E.

Mol Cancer. 2014 May 20;13:114. doi: 10.1186/1476-4598-13-114.

8.

Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.

Park J, Choi Y, Namkung J, Yi SG, Kim H, Yu J, Kim Y, Kwon MS, Kwon W, Oh DY, Kim SW, Jeong SY, Han W, Lee KE, Heo JS, Park JO, Park JK, Kim SC, Kang CM, Lee WJ, Lee S, Han S, Park T, Jang JY, Kim Y.

Oncotarget. 2017 Oct 16;8(54):93117-93130. doi: 10.18632/oncotarget.21861. eCollection 2017 Nov 3. Erratum in: Oncotarget. 2018 Jan 12;9(4):5514.

9.

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.

Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BB.

Clin Cancer Res. 2019 Jan 7. doi: 10.1158/1078-0432.CCR-18-3310. [Epub ahead of print]

PMID:
30617132
10.

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.

Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK.

EBioMedicine. 2019 Apr 4. pii: S2352-3964(19)30201-4. doi: 10.1016/j.ebiom.2019.03.056. [Epub ahead of print]

11.

MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.

JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664.

PMID:
24449318
12.

Development of serum parameters panels for the early detection of pancreatic cancer.

Zhang P, Zou M, Wen X, Gu F, Li J, Liu G, Dong J, Deng X, Gao J, Li X, Jia X, Dong Z, Chen L, Wang Y, Tian Y.

Int J Cancer. 2014 Jun 1;134(11):2646-55. doi: 10.1002/ijc.28584. Epub 2013 Nov 19.

13.

Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.

Sogawa K, Takano S, Iida F, Satoh M, Tsuchida S, Kawashima Y, Yoshitomi H, Sanda A, Kodera Y, Takizawa H, Mikata R, Ohtsuka M, Shimizu H, Miyazaki M, Yokosuka O, Nomura F.

Br J Cancer. 2016 Oct 11;115(8):949-956. doi: 10.1038/bjc.2016.295. Epub 2016 Sep 22.

14.

Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.

Hogendorf P, Durczyński A, Skulimowski A, Kumor A, Poznańska G, Strzelczyk J.

Cancer Biomark. 2018 Feb 14;21(3):505-511. doi: 10.3233/CBM-170203.

PMID:
29171983
15.

Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.

Wang X, Li Y, Tian H, Qi J, Li M, Fu C, Wu F, Wang Y, Cheng D, Zhao W, Zhang C, Wang T, Rao J, Zhang W.

BMC Cancer. 2014 Aug 8;14:578. doi: 10.1186/1471-2407-14-578.

16.

Serum biomarker panels for the detection of pancreatic cancer.

Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, Elton E, Arnoletti JP, Christein JD, Vickers SM, Langmead CJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE.

Clin Cancer Res. 2011 Feb 15;17(4):805-16. doi: 10.1158/1078-0432.CCR-10-0248.

17.

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.

Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban RH, Breit SN, Kinzler KW, Vogelstein B, Goggins M.

Clin Cancer Res. 2004 Apr 1;10(7):2386-92.

18.

Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.

Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.

Clin Transl Gastroenterol. 2019 Apr 15. doi: 10.14309/ctg.0000000000000029. [Epub ahead of print]

PMID:
31009404
19.

MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.

Vila-Navarro E, Vila-Casadesús M, Moreira L, Duran-Sanchon S, Sinha R, Ginés À, Fernández-Esparrach G, Miquel R, Cuatrecasas M, Castells A, Lozano JJ, Gironella M.

Ann Surg. 2017 Jun;265(6):1226-1234. doi: 10.1097/SLA.0000000000001809.

20.

High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm.

Aronsson L, Andersson R, Bauden M, Andersson B, Bygott T, Ansari D.

Scand J Gastroenterol. 2018 Dec;53(12):1597-1603. doi: 10.1080/00365521.2018.1532020. Epub 2018 Dec 3.

PMID:
30509115

Supplemental Content

Support Center